DOCSLIB.ORG

Peer Reviewer Nominations Packet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Cancer Prevention and Research Institute of Texas Oversight Committee Nominations Subcommittee Meeting May 13, 2014 Basic Cancer Research Panel 1 Tom Curran, Ph.D./FRS, Chair Peer Review Panel Members for Approval 1. Allan Balmain, Ph.D. 2. Steve Fiering, Ph.D. 3. Jacquelyn Hank, Ph.D. 4. Frank Rauscher, Ph.D. 5. Heide Schatten, Ph.D. 6. Joshua Schiffman, M.D. 7. Bart Williams, Ph.D. 8. Yu-Ching Yang, Ph.D. BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors in the order listed on Form Page 2. Follow this format for each person. DO NOT EXCEED FOUR PAGES. NAME POSITION TITLE Balmain, Allan Professor in Residence eRA COMMONS USER NAME (credential, e.g., agency login) abalmain EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable.) DEGREE INSTITUTION AND LOCATION (if applicable) MM/YY FIELD OF STUDY University of Glasgow BSc 1966 Hons. Chemistry University of Glasgow PhD 1969 Organic Chemistry German Cancer Research Centre, Heidelberg, Postdoctoral 1971-72 West Germany University of Strasbourg, France Postdoctoral 1969-71 A. Personal Statement The goal of our research is to identify the genetic events that underlie multistage epithelial tumor development, using mouse models of cancer. We have focused on models that recapitulate the genetic heterogeneity in human populations, with a view to development of approaches to personalized diagnosis and treatment. The models used have primarily been focused on skin, but also include comparative analyses of lung carcinomas and lymphoma. The focus of the most recent projects is the development of “Systems Genetics” approaches to analysis of multistage carcinogenesis. These seek to integrate multidimensional data sets to provide a network view of normal genetic architecture in mouse and human tissues, and the perturbations that take place during development of benign tumors and their progression to metastasis. Studies to date have revealed important roles for genes and pathways linked to stem cell fate decisions, cell cycle control, and inflammation. These gene expression network approaches represent a novel and highly promising route to the identification of the critical interacting components of important cancer signaling pathways. B. Professional Experience 1972-1976 Tenured member of staff, German Cancer Research Centre, Heidelberg, Germany 1976-1982 Staff Scientist, Beatson Institute for Cancer Research, Glasgow 1982-1994 Group Leader, Beatson Institute for Cancer Research, Glasgow 1984-1994 CRC Special Appointment 1994-1996 Director of Laboratory Research, Professor of Molecular Oncology, University of Glasgow, Jerry Turner Fellow of the Cancer Research Campaign 1996-1999 Vice President, Research, Onyx Pharmaceuticals, Richmond CA 1999-2001 Professor of Cancer Genetics, Cancer Research Institute and Department of Biochemistry and Biophysics, University of California-San Francisco 2001-present: Barbara Bass Bakar Distinguished Professor of Cancer Genetics, UCSF Helen Diller Family Comprehensive Cancer Center Co-Leader, UCSF Cancer Genetics Program. Director, Genome Analysis Core Honors 1970 Royal Society European Programme Fellowship 1971 Alexander Von Humboldt-Stiftung Fellowship 1991 Keynote Lecture, UK MBCN, Warwick 1992 Distinguished Lecturer Series, Yale University 1993 Keynote Lecture, ECCO 7 London 1995 Fellow of the Royal Society of Edinburgh 1999 UICC Roll of Honor 2000 Tom Connors Prize and Lecture, British Association for Cancer Research Program Director/Principal Investigator: (Last, first, middle) Balmain, Allan 2003 Distinguished Lecturer Series, Harvard University School of Public Health 2004 Distinguished Visitor, Biomedical Research Council, Singapore 2004 The DiMaggio Lecture, Dana Farber Cancer Center 2006 Opening lecture, AACR conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, Hawaii 2007 The Cori Award Lecture, Roswell Park, Buffalo, NY 2007 Keynote Address, CCRI, University of Texas, San Antonio, TX 2007 John B. Little Award, Harvard School of Public Health 2008 Keynote lecture, McArdle Cancer Center Symposium 2008 Keynote Lecture, European Symposium on Hormones and Cell Regulation Mont Ste Odile, France 2009 Keynote Lecture and J.Walter Juckett Distinguished Lecture, Vermont Cancer Center 2010 Keynote Lecture, 56th Annual Radiation Research Society Symposium, Hawaii 2010 Keynote Lecture, University of Maastricht Genetics Meeting, Maastricht 2011 American Skin Association Achievement Award 2013 Herman Beerman Award, Society for Investigative Dermatology 2013 Elected Fellow of the American Academy of Arts and Sciences. C. Selected Peer-reviewed Publications (from last 10 years). 1. To MD, Perez-Losada J , Mao J-H , Hsu J , Jacks T, Balmain A. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nature Genetics. 2006 Aug;38(8):926- 30. 2. Wakabayashi Y, Mao, JH, Brown K, Girardi M and Balmain A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature. 2007 Feb 15;445(7129):761-5. 3. Mao JH, Wu D; Perez-Losada J, Jiang T, Li Q; Neve RM, Gray JW, Cai WW, Balmain A. Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice. Cancer Cell. 2007 Feb;11(2):161-73. 4. To MD, Wong CE, Karnezis AN,Del Rosario R, Di Lauro R, and Balmain A. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer, Nature Genetics. 2008 Oct;40(10):1240-4. 5. Mao JH, Kim IJ, Wu D, Climent J, Kang HC, DelRosario R, Balmain A. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science. 2008 Sep 12;321(5895):1499- 502. 6. Quigley DA, To MD, Pérez-Losada J, Pelorosso FG, Mao JH, Nagase H, Ginzinger DG, and Balmain A. Genetic architecture of mouse skin inflammation and tumor susceptibility. Nature. 2009 Mar 26;458(7237):505-8. 7. Quigley DA, To MD, Kim IJ, Lin, K, Albertson DG, Sjolund J, Pérez-Losada J and Balmain A. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biology 2011, 12:R 8. Wang YV, Leblanc M, Fox N, Mao JH, Tinkum KL, Krummel K, Engle D, Piwnica-Worms D, Piwnica- Worms H, Balmain A, Kaushansky K, Wahl GM. Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev. 2011 Jul 1;25(13):1426-38 9. Mao JH, Wu D, Kim IJ, Kang HC, Wei G, Climent J, Kumar A, Pelorosso FG, Delrosario R, Huang EJ, Balmain A. Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma. Oncogene. 2011 Jul 25. doi: 10.1038/onc.2011.306. 10. To MD, Quigley DA, Mao JH, Del Rosario R, Hsu J, Hodgson G, Jacks T, Balmain A. Progressive Genomic Instability in the FVB/KrasLA2 Mouse Model of Lung Cancer. Mol Cancer Res. 2011 Sep 20. 11. To MD, Rosario, RD, Westcott, PM, Banta KL, Balmain A. Interactions between wild type and mutant Ras genes in lung and skin carcinogenesis. Oncogene. 2012 Sep 3. doi: 10.1038/onc.2012.404 12. Kang, HC, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D’Alessandro, M, Lane EB, Akhurst RJ, Goudie DR and Balmain A. Multiple Self-Healing Squamous Epithelioma (MSSE): rare PHS 398/2590 (Rev. 06/09) Page ___ Other Support Format Page BIOGRAPHICAL SKETCH NAME POSITION TITLE Steven N. Fiering, Ph.D. Associate Professor eRA COMMONS USER NAME SNFIERING EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) DEGREE INSTITUTION AND LOCATION (if YEAR(s) FIELD OF STUDY applicable) University of Michigan, Ann Arbor B.S. 1969-1975 Geology Eastern Michigan University M.S. 1983-1984 Microbiology Stanford University Ph.D. 1985-1990 Genetics Fred Hutchinson Cancer Research Ctr., Seattle Postdoc 1991-1997 Genetics A. Personal statement I established the Dartmouth Transgenic and Genetic Construct Shared Resource upon my recruitment to Dartmouth in 1997 and have directed it since. In 2002 the Core C of the Immunology INBRE was funded as part of that grant and we have developed and provided genetically modified and experimentally manipulated mice under that grant ever since. The Immunology INBRE is in its third round of funding and we are focused on providing published immunologically relevant mouse models that are not currently available at Dartmouth. In that context we have established the ability to generate mice with humanized lymphocyte compartments and plan to continue to expand on that to include mice with myeloid as well as lymphoid humanization through hydrodynamic injection of human cytokine plasmids. We are enthused to collaborate with Dr. Berwin on developing these new models and providing them to him for experimental use. B. Positions and Honors Employment / Experience 1975-1982 The Soy Plant, Ann Arbor, MI, Partner in a food processing business. 9/82-12/84 Eastern Michigan University, Teaching Assistant, Microbiology 9/85- 9/90 Graduate student in the laboratory of Dr. Len Herzenberg at Stanford 10/90-9/91 Research Group Leader, AFRC Centre for Genome Research, Edinburgh, Scotland 10/91-6/97 Postdoctoral Fellow in the lab of Dr. Mark Groudine, Fred Hutchinson Cancer Research Center 6/97-7/04 Assistant Professor, Dept. of Microbiology/Immunology, Dartmouth Medical School 7/01-7/04 Assistant Professor Genetics
Recommended publications
  • AAO of the FUTURE AAO of Next Generation Fibre Positioning Robots

    AAO of the FUTURE AAO of Next Generation Fibre Positioning Robots

    IAU SPECIAL EDITION JULY 2003 NEWSLETTER ANGLO-AUSTRALIAN OBSERVATORY AAO OF THE FUTURE Next generation fibre positioning robots. Microrobotic technology based on the AAO’s Echidna system allows accurate positioning of payloads such as single fibres, guide bundles, mini- IFUs or even pick-off mirrors to be accurately positioned on large focal plates for large and ‘extremely large’ telescopes. See article on page 18. contents 3The Anglo-Australian Planet Search finDs a new “Solar System”-like gas giant (Chris Tinney et al.) 4RAVE hits the galaxy (FreD Watson et al.) 8A search for the highest reDshift raDio galaxies (Carlos De Breuck et al.) 9The 6DF Galaxy Survey (Will SaunDers et al.) 14 The end of observations for the 2dF Galaxy Redshift Survey (Matthew Colless et al.) 18 Directions for future instrumentation Development by the AAO (AnDrew McGrath et al.) 20 AAΩ: the successor to 2dF (Terry Bridges et al.) DIRECTOR’S MESSAGE DIRECTOR’S DIRECTOR’S MESSAGE On behalf of the staff of the Anglo-Australian Observatory, I would like to extend a warm welcome to Sydney to all IAU General Assembly delegates. This special GA edition of the AAO newsletter showcases some of the AAO’s achievements over the past year as well as some exciting new directions in which the AAO is heading in the future. Over the past few years the AAO has increasingly sought to build on its scientific and technical expertise through the design and building of astronomical instrumentation for overseas observatories, whilst maintaining its own telescopes as world-class facilities. The success of science programs such as the Anglo-Australian Planet Search and the 2dF Galaxy Redshift Survey amply demonstrate that the AAO is still facilitating the production of outstanding science by its user communities.
  • Ploidetect Enables Pan-Cancer Analysis of the Causes and Impacts of Chromosomal Instability

    Ploidetect Enables Pan-Cancer Analysis of the Causes and Impacts of Chromosomal Instability

    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.06.455329; this version posted August 8, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Ploidetect enables pan-cancer analysis of the causes and impacts of chromosomal instability Luka Culibrk1,2, Jasleen K. Grewal1,2, Erin D. Pleasance1, Laura Williamson1, Karen Mungall1, Janessa Laskin3, Marco A. Marra1,4, and Steven J.M. Jones1,4, 1Canada’s Michael Smith Genome Sciences Center at BC Cancer, Vancouver, British Columbia, Canada 2Bioinformatics training program, University of British Columbia, Vancouver, British Columbia, Canada 3Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada 4Department of Medical Genetics, Faculty of Medicine, Vancouver, British Columbia, Canada Cancers routinely exhibit chromosomal instability, resulting in tumors mutate, these variants are considerably more difficult the accumulation of changes in the abundance of genomic ma- to detect accurately compared to other types of mutations terial, known as copy number variants (CNVs). Unfortunately, and consequently they may represent an under-explored the detection of these variants in cancer genomes is difficult. We facet of tumor biology. 20 developed Ploidetect, a software package that effectively iden- While small mutations can be determined through base tifies CNVs within whole-genome sequenced tumors. Ploidetect changes embedded within aligned sequence reads, CNVs was more sensitive to CNVs in cancer related genes within ad- are variations in DNA quantity and are typically determined vanced, pre-treated metastatic cancers than other tools, while also segmenting the most contiguously.

  • Professor Peter Goldreich Member of the Board of Adjudicators Chairman of the Selection Committee for the Prize in Astronomy

    The Shaw Prize The Shaw Prize is an international award to honour individuals who are currently active in their respective fields and who have recently achieved distinguished and significant advances, who have made outstanding contributions in academic and scientific research or applications, or who in other domains have achieved excellence. The award is dedicated to furthering societal progress, enhancing quality of life, and enriching humanity’s spiritual civilization. Preference is to be given to individuals whose significant work was recently achieved and who are currently active in their respective fields. Founder's Biographical Note The Shaw Prize was established under the auspices of Mr Run Run Shaw. Mr Shaw, born in China in 1907, was a native of Ningbo County, Zhejiang Province. He joined his brother’s film company in China in the 1920s. During the 1950s he founded the film company Shaw Brothers (HK) Limited in Hong Kong. He was one of the founding members of Television Broadcasts Limited launched in Hong Kong in 1967. Mr Shaw also founded two charities, The Shaw Foundation Hong Kong and The Sir Run Run Shaw Charitable Trust, both dedicated to the promotion of education, scientific and technological research, medical and welfare services, and culture and the arts. ~ 1 ~ Message from the Chief Executive I warmly congratulate the six Shaw Laureates of 2014. Established in 2002 under the auspices of Mr Run Run Shaw, the Shaw Prize is a highly prestigious recognition of the role that scientists play in shaping the development of a modern world. Since the first award in 2004, 54 leading international scientists have been honoured for their ground-breaking discoveries which have expanded the frontiers of human knowledge and made significant contributions to humankind.
  • Marc Corrales Berjano

    Marc Corrales Berjano

    Text in context: Chromatin effects in gene regulation Marc Corrales Berjano TESI DOCTORAL UPF / 2017 DIRECTOR DE LA TESI Dr. Guillaume Filion DEPARTAMENT Gene Regulation, Stem cells and Cancer Genome architecture Center for Genomic Regulation (CRG) ii a mi familia, iii Aknowledgements I want to thank the members of the doctoral board, present and substitutes, for accepting to analize my work and defend my thesis. I also want to thank my thesis commitee Dr. Miguel Beato, Dr. Jordi Garcia-Ojalvo and Dr. Tanya Vavouri for guidance and valuable scientific imput whenever I needed it along these years. I want to thank my mentor Dr. Guillaume Filion, not only for giving me the opportunity to carry this work in a wonderful environement, but for teaching me. No matter the tigh schedule he has allowed me to sit by his side (literally) reviewing a script at the computer, calculating the probaility of plasmid recircularization or deriving a statistical formula at the white board but also helping me to prepare and electroporate a bacterial library in what seemed a contraction of space-time. I want to thank the community of the CRG, always ready to discuss science and life in the corridors, the data seminars, symposiums, the beer sessions or following a mail asking for advice or materials. People at the administration helped enormously to navigate the tortuous bureaucratic world, maximizing the time one can dedicate toscience. ¡Dónde estaría yo sin tu puerta siempre abierta, Imma, madre en funciones de todo phD student! I want to thank the CRG for funding my phD and for constituting what I envisage as the perfect environment to learn to be a scientist.
  • 2019 Annual Report

    2019 Annual Report

    BECKMAN CENTER 279 Campus Drive West Stanford, CA 94305 650.723.8423 Stanford University | Beckman Center 2019 Annual Report Annual 2019 | Beckman Center University Stanford beckman.stanford.edu 2019 ANNUAL REPORT ARNOLD AND MABEL BECKMAN CENTER FOR MOLECULAR AND GENETIC MEDICINE 30 Years of Innovation, Discovery, and Leadership in the Life Sciences CREDITS: Cover Design: Neil Murphy, Ghostdog Design Graphic Design: Jack Lem, AlphaGraphics Mountain View Photography: Justin Lewis Beckman Center Director Photo: Christine Baker, Lotus Pod Designs MESSAGE FROM THE DIRECTOR Dear Friends and Trustees, It has been 30 years since the Beckman Center for Molecular and Genetic Medicine at Stanford University School of Medicine opened its doors in 1989. The number of translational scientific discoveries and technological innovations derived from the center’s research labs over the course of the past three decades has been remarkable. Equally remarkable have been the number of scientific awards and honors, including Nobel prizes, received by Beckman faculty and the number of young scientists mentored by Beckman faculty who have gone on to prominent positions in academia, bio-technology and related fields. This year we include several featured articles on these accomplishments. In the field of translational medicine, these discoveries range from the causes of skin, bladder and other cancers, to the identification of human stem cells, from the design of new antifungals and antibiotics to the molecular underpinnings of autism, and from opioids for pain
  • Chemistry NEWSLETTER

    Chemistry NEWSLETTER

    University of Michigan DEPARTMENT OF Chemistry NEWSLETTER Letter from the Chair Greetings from Ann Arbor and the chemical biology. In addition to these that Jim has done. He will be replaced by Department of Chemistry. After one full two outstanding senior hires, we welcome Professor Masato Koreeda. Professor year as Department Chair, I have come to Dr. Larry Beck from Cal Tech as the Dow Mark Meyerhoff will continue as Associ- realize the full scope of this administra- CorningAssistant Professor of analytical ate Chair for Graduate Student Affairs for tive challenge. It’s been a very busy and chemistry in September. Larry brings a another year after which he will take a exciting year as we forge ahead to meet broad spectrum of research expertise in well deserved sabbatical leave. the goals and implement the plans set out solid state NMR, zeolites and We have had another excellent year for in our new 5-year plan. nanostructures. Faculty recruiting will recruiting graduate students. In the fall, One of the most ambitious parts of our continue at a vigorous pace in the coming 45 new Ph.D. students will join the De- plan is the recruitment of new faculty at year with no less than four searches in the partment. This summer has also been a the senior and junior levels. During the area of theoretical physical chemistry, very productive one for undergraduate past year, Professor William Roush organic and chemical biology and inor- research participation with a total of 20 settled in the Department as the first ganic/materials chemistry.
  • Course Number and Title: CAS AH 374 Australian Art and Architecture

    Course Number and Title: CAS AH 374 Australian Art and Architecture

    Course Number and Title: CAS AH 374 Australian Art and Architecture Instructor/s Name/s: Peter Barnes Course Dates: Spring Semester, Fall Semester Office Location: BU Sydney Programs, Australia, a division of BU Study Abroad Course Time: Two sessions per week in accordance with class schedule: one session of 4 + hours and one session of 2 hours in a 7-8 week teaching half of a semester. Location: Classrooms, BU Sydney Academic Centre, Sydney, Australia, and multiple out-of-classroom field trips as scheduled, one of which is a 12 hour day long field trip outside the city to Canberra, Australia’s national capital and home to National Art Galleries, and Museums. Course Credits: 4 BU credits plus 2 BU Hub units Contact Information: [email protected] Office Hours: 15 minutes prior to and following course delivery or by appointment. TA/TF/Learning Assistant information, if relevant: 0 Principal Lecturers: Peter Barnes Guest Lecturers: Vary in accordance with available artists. One example is: Tom Carment, a working artist Question-driven Course Description: *How have European art traditions influenced the art practice of Australia’s indigenous peoples and how in turn has Aboriginal culture impacting the art of non-indigenous Australians? *The 18th century voyages to the southern ocean placed artists in a prominent role as practitioners of the new science of observation and experimentation promoted by the Royal Society. How does this differ from the idealist aesthetics of the Royal academy and what impact did this have on art in Australia during
  • Finding the Radiation from the Big Bang

    Finding the Radiation from the Big Bang

    Finding The Radiation from the Big Bang P. J. E. Peebles and R. B. Partridge January 9, 2007 4. Preface 6. Chapter 1. Introduction 13. Chapter 2. A guide to cosmology 14. The expanding universe 19. The thermal cosmic microwave background radiation 21. What is the universe made of? 26. Chapter 3. Origins of the Cosmology of 1960 27. Nucleosynthesis in a hot big bang 32. Nucleosynthesis in alternative cosmologies 36. Thermal radiation from a bouncing universe 37. Detecting the cosmic microwave background radiation 44. Cosmology in 1960 52. Chapter 4. Cosmology in the 1960s 53. David Hogg: Early Low-Noise and Related Studies at Bell Lab- oratories, Holmdel, N.J. 57. Nick Woolf: Conversations with Dicke 59. George Field: Cyanogen and the CMBR 62. Pat Thaddeus 63. Don Osterbrock: The Helium Content of the Universe 70. Igor Novikov: Cosmology in the Soviet Union in the 1960s 78. Andrei Doroshkevich: Cosmology in the Sixties 1 80. Rashid Sunyaev 81. Arno Penzias: Encountering Cosmology 95. Bob Wilson: Two Astronomical Discoveries 114. Bernard F. Burke: Radio astronomy from first contacts to the CMBR 122. Kenneth C. Turner: Spreading the Word — or How the News Went From Princeton to Holmdel 123. Jim Peebles: How I Learned Physical Cosmology 136. David T. Wilkinson: Measuring the Cosmic Microwave Back- ground Radiation 144. Peter Roll: Recollections of the Second Measurement of the CMBR at Princeton University in 1965 153. Bob Wagoner: An Initial Impact of the CMBR on Nucleosyn- thesis in Big and Little Bangs 157. Martin Rees: Advances in Cosmology and Relativistic Astro- physics 163.
  • Sugar Coated Sugar Has Become Notorious, with Countless Claims of Its Ill Effects on Health

    Sugar Coated Sugar Has Become Notorious, with Countless Claims of Its Ill Effects on Health

    HHMI BULLETIN N OV . ’11 VOL.24 • NO.04 • 4000 Jones Bridge Road Chevy Chase, Maryland 20815-6789 Hughes Medical Institute Howard www.hhmi.org Address Service Requested Sugar Coated Sugar has become notorious, with countless claims of its ill effects on health. But not all sugars are bad for you. Consider fucose, an essential sugar the body needs. Without it, neurons can’t communicate, kidneys can’t filter blood, and skin can’t stay hydrated. Chemical biologist Carolyn • Bertozzi and her group are trying to learn more about the role of fucose in www.hhmi.org development. To do this, they injected modified versions of fucose into live, single-celled zebrafish embryos. As the embryos developed, the altered fucose molecules were incorporated into the sugars that coat cell surfaces. Using a simple chemical reaction, the team attached a labeled probe molecule to the altered fucose so they could visualize its location in the developing embryo. In this image of a 19-hour-old zebrafish embryo, labeled fucose (red) glows in the peripheral cells. Just one of many ways chemistry is helping answer biological questions (see “Living Chemistry,” page 12). YEAR OF CHEMISTRY Chemists fascinated by the complexity of biology are solving problems in neuroscience, immunology, and cell signaling. v ol. 24 / no. no. / Karen Dehnert and Scott Laughlin / Bertozzi lab In This Issue: Traveling Microscope / Lemur vs Mouse / Spotlight on Science Teacher Training 04 ObservatiOns ThE GIvInG TREE The history of science overflows with captivating stories of break- Johann Kraut in 1869 and Hermann Kolbe in 1874, but then, unfortunately, throughs that led to innovative disease treatments.
  • The Future of Cosmology 3

    The Future of Cosmology 3

    IL NUOVO CIMENTO Vol. ?, N. ? ? The Future of Cosmology George Efstathiou Institute of Astronomy, Madingley Road, Cambridge, CB3 OHA. England. Summary. — This article is the written version of the closing talk presented at the conference ‘A Century of Cosmology’ held at San Servolo, Italy, in August 2007. I focus on the prospects of constraining fundamental physics from cosmological observations, using the search for gravitational waves from inflation and constraints on the equation of state of dark energy as topical examples. I argue that it is important to strike a balance between the importance of a scientific discovery against the likelihood of making the discovery in the first place. Astronomers should be wary of embarking on large observational projects with narrow and speculative scientific goals. We should maintain a diverse range of research programmes as we move into a second century of cosmology. If we do so, discoveries that will reshape fundamental physics will surely come. 1. – Introduction It is a privilege to be invited to give the closing talk at this meeting celebrating ‘A Century of Cosmology’. I have taken the liberty of changing the title of the written version to make it shorter and snappier. Of course, I will not be able to cover all of arXiv:0712.1513v2 [astro-ph] 4 Jan 2008 cosmology and I am not a clairvoyant. What I will try to do is to review a small number of topics and use them as a guide to how our subject might develop. I am told that a good high court judge leaves everybody in the courtroom dissatisfied.
  • Teri Melese, Ph.D

    Teri Melese, Ph.D

    Prepared: 02/015 University of California, San Diego Curriculum Vitae Name: Teri Melese, Ph.D Current Position: UCSD Assistant Vice Chancellor, Industry Research Alliances Adjunct Associate Professor, Department of Medicine and Rady School of Management Last Position Held: Adjunct Associate Professor UCSF Department of Medicine, School of Medicine, 2005-2012 UCSF Dean’s Office: Director of Business Strategy and Development, School of Medicine UCSF Helen Diller Comprehensive Cancer Center Executive Committee: Associate Director for Strategic Alliances Address: University of California, San Diego Office of Research Affairs 9500 Gilman Drive #0910 La Jolla, CA 92093-0043 Tel: (858) 822-5247 mobile: (408) 373-3651 [email protected] Education: 1975-77 University of California, Berkeley A.B. Neurobiology/ Literature 1977-82 University of California, San Francisco Ph.D. Regents Fellow 1982-86 University of California, Los Angeles Postdoctoral Fellow Biochemistry 1986-87 University of California, Los Angeles American Cancer Sr. Research Fellow Molecular Biology Principal Positions Held: 1988-92 Columbia University, New York Assistant Professor Biological Sciences 1993-97 Columbia University, New York Associate Professor Biological Sciences 1997-99 Columbia University, New York Adjunct Associate Professor Biological Sciences 1997-01 Iconix Pharmaceuticals Mountain View Founding Member & Director Chemical Genomics 2001-2012 University of California, San Francisco Adjunct Full Professor Step II Medicine Present University of California, San Diego
  • Molecular Chaperones in Cancer

    Molecular Chaperones in Cancer

    CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER IN MEMORY OF SUSAN LINDQUIST Organisers Nabil Djouder Spanish National Cancer Research Centre (CNIO), Madrid, Spain Wilhelm Krek Institute for Molecular Health Sciences Zurich, Switzerland Paul Workman The Institute of Cancer Research London, UK Xiaohong Helena Yang Cancer Cell Cambridge, US EXCELENCIA MINISTERIO DE ECONOMÍA, INDUSTRIA SEVERO Y COMPETITIVIDAD OCHOA CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER Summary 07 PROGRAMME 19 KEYNOTE LECTURE 23 SESSIONS 23 S #1 PROTEIN QUALITY CONTROL 31 S #2 FOLDING, MISFOLDING AND AGGREGATION 41 S #3 STRESS MECHANISMS IN CANCER 49 S #4 CHAPERONES IN CANCER 59 S #5 TARGETING CHAPERONES: CHAPERONOTHERAPY 67 CLOSING LECTURE 69 ORGANISERS AND SPEAKERS’ BIOGRAPHIES 99 POSTER SESSIONS 119 Previous CNIO Frontiers Meetings and CNIO Cancer Conferences 05 CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER PROGRAMME 07 PROGRAMME Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER Venue: Spanish National Cancer Research Centre – CNIO Auditorium, Madrid, Spain Chairpersons and organizing committee: Nabil Djouder, Spanish National Cancer Research Centre, Madrid, Spain Wilhelm Krek, Institute for Molecular Health Sciences, ETH, Zurich, Switzerland Paul Workman, The Institute of Cancer Research, London, UK Xiaohong Helena Yang, Cancer Cell, Cambridge, USA Rationale: Molecular chaperones play key roles in the folding, stability and activity of proteins in normal cell homeostasis and disease pa- thology, including cancer.